Replies to post #151483 on Biotech Values

[DewDiligence]

AGN is aware of this problem; from the 3Q12 CC:

http://seekingalpha.com/article/962971-allergan-management-discusses-q3-2012-results-earnings-call-transcript

Since the last earnings report, we have trained 200 more individual physicians. Focus is now on deepening the level of training…rather than just training de novo injectors…

Our investments in both branded and non-branded DTC campaigns for BOTOX for chronic migraine are driving patients to our websites for information about the condition and also where to find a headache specialist… We are pleased that, in the recent physician survey, Allergan is now perceived as the #1 company in migraine management by physicians.